- Recent correction and pullback in Baxter's price has turned the tables on valuation, thus presenting an exciting entry point.
- Current DCF valuation highlights a +5% value gap to the upside.
- Baxter has bounced off the long-term support line at least 5 times previously, and is currently being tested at the current support level.
- We firmly believe that the fundamental outlook coupled with the valuation elicits a bullish long term picture, which we have advocated previously.
For further details see:
Baxter Is A Buy At Current Valuation - We Call A Value Play Into 2021